A citation-based method for searching scientific literature

Omkar U Kawalekar, Roddy S O'Connor, Joseph A Fraietta, Lili Guo, Shannon E McGettigan, Avery D Posey, Prachi R Patel, Sonia Guedan, John Scholler, Brian Keith, Nathaniel W Snyder, Ian A Blair, Michael C Milone, Carl H June. Immunity 2016
Times Cited: 409



Marco L Davila, Isabelle Riviere, Xiuyan Wang, Shirley Bartido, Jae Park, Kevin Curran, Stephen S Chung, Jolanta Stefanski, Oriana Borquez-Ojeda, Malgorzata Olszewska, Jinrong Qu, Teresa Wasielewska, Qing He, Mitsu Fink, Himaly Shinglot, Maher Youssif, Mark Satter, Yongzeng Wang, James Hosey, Hilda Quintanilla, Elizabeth Halton, Yvette Bernal, Diana C G Bouhassira, Maria E Arcila, Mithat Gonen, Gail J Roboz, Peter Maslak, Dan Douer, Mark G Frattini, Sergio Giralt, Michel Sadelain, Renier Brentjens. Sci Transl Med 2014
Times Cited: 1480




List of shared articles



Times cited


Next-generation CAR T cells to overcome current drawbacks.
Stefan Lundh, Sayantan Maji, J Joseph Melenhorst. Int J Hematol 2021
2

Development and functional characterization of novel fully human anti-CD19 chimeric antigen receptors for T-cell therapy.
Zhenyu Dai, Xuelian Hu, Xiangyin Jia, Jianwei Liu, Yongkun Yang, Panpan Niu, Guang Hu, Taochao Tan, Jianfeng Zhou. J Cell Physiol 2021
1

Challenges and Clinical Strategies of CAR T-Cell Therapy for Acute Lymphoblastic Leukemia: Overview and Developments.
Xinjie Xu, Shengkang Huang, Xinyi Xiao, Qihang Sun, Xiaoqian Liang, Sifei Chen, Zijing Zhao, Zhaochang Huo, Sanfang Tu, Yuhua Li. Front Immunol 2021
2

Fueling the Revolution: Targeting Metabolism to Enhance Immunotherapy.
Robert D Leone, Jonathan D Powell. Cancer Immunol Res 2021
1


CAR T cell therapy as a promising approach in cancer immunotherapy: challenges and opportunities.
Maryam Akhoundi, Mahsa Mohammadi, Seyedeh Saeideh Sahraei, Mohsen Sheykhhasan, Nashmin Fayazi. Cell Oncol (Dordr) 2021
2

Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy.
Guillermo O Rangel Rivera, Hannah M Knochelmann, Connor J Dwyer, Aubrey S Smith, Megan M Wyatt, Amalia M Rivera-Reyes, Jessica E Thaxton, Chrystal M Paulos. Front Immunol 2021
3

CAR-T cell therapy: current limitations and potential strategies.
Robert C Sterner, Rosalie M Sterner. Blood Cancer J 2021
12


A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains.
Kathryn M Cappell, James N Kochenderfer. Nat Rev Clin Oncol 2021
3


Chimeric antigen receptor T-cell therapy: An emergency medicine focused review.
Brit Long, Michael J Yoo, William J Brady, Angela Holian, Amita Sudhir, Michael Gottlieb. Am J Emerg Med 2021
0

Identifying and managing CAR T-cell-mediated toxicities: on behalf of an Italian CAR-T multidisciplinary team.
Massimo Martino, Sebastiano Macheda, Umberto Aguglia, Luciano Arcudi, Giulia Pucci, Bruno Martino, Maria Altomonte, Antonio Maria Rossetti, Giuseppa Cusumano, Letteria Russo,[...]. Expert Opin Biol Ther 2021
0

Advances and Challenges of CAR T Cells in Clinical Trials.
Astrid Holzinger, Hinrich Abken. Recent Results Cancer Res 2020
6

Determinants of response and resistance to CAR T cell therapy.
Stefanie Lesch, Mohamed-Reda Benmebarek, Bruno L Cadilha, Stefan Stoiber, Marion Subklewe, Stefan Endres, Sebastian Kobold. Semin Cancer Biol 2020
23

Preclinical Activity of Embryonic Annexin A2-Specific Chimeric Antigen Receptor T Cells Against Ovarian Cancer.
Leonard Leong, Heng Liang Tan, Simeon Cua, Kylie Su Mei Yong, Qingfeng Chen, Andre Choo. Int J Mol Sci 2020
7